Catecholamine Metabolism: A Contemporary View with Implications for Physiology and Medicine

Eisenhofer, Graeme, Kopin, Irwin J., Goldstein, David S.·2004·Pharmacological Reviews

Cited by (1,002)

Items 101–200 of 1,002

  1. Dopamine Synthesis and D3 Receptor Activation in Pancreatic β-Cells Regulates Insulin Secretion and Intracellular [Ca2+] Oscillations
    Alessandro Ustione, David W. Piston · 2012 · Molecular Endocrinology
  2. Inhibitors of MAO-B and COMT: their effects on brain dopamine levels and uses in Parkinson’s disease
    John P.M. Finberg · 2018 · Journal of Neural Transmission
  3. Minireview: Dopaminergic Regulation of Insulin Secretion from the Pancreatic Islet
    Alessandro Ustione, David W. Piston, Paul E. Harris · 2013 · Molecular Endocrinology
  4. Interactions of dopamine, iron, and alpha-synuclein linked to dopaminergic neuron vulnerability in Parkinson's disease and Neurodegeneration with Brain Iron Accumulation disorders
    Rachel M. Wise, Annika Wagener, Urban M. Fietzek, Thomas Klopstock, Eugene V. Mosharov, Fabio Andrea Zucca, David L. Sulzer, Luigi Zecca, Lena F. Burbulla · 2022 · Neurobiology of Disease
  5. Interaction of alpha-synuclein and dopamine metabolites in the pathogenesis of Parkinson’s disease: a case for the selective vulnerability of the substantia nigra
    James E. Galvin · 2006 · Acta Neuropathologica
  6. Bioavailability of the phenolic compounds of the fruits (drupes) of Olea europaea (olives): Impact on plasma antioxidant status in humans
    Aggeliki M. Kountouri, A. Mylona, Andriana C. Kaliora, Nikolaos K. Andrikopoulos · 2007 · Phytomedicine
  7. Reduced Sympathetic Metabolites in Urine of Obese Patients With Craniopharyngioma
    Christian Ludwig Roth, Donald H. HUNNEMAN, U Gebhardt, Birgit Stoffel‐Wagner, Thomas Reinehr, Hermann Lothar Muller · 2007 · Pediatric Research
  8. Catecholamine-Induced Cardiomyopathy in Pheochromocytoma: How to Manage a Rare Complication in a Rare Disease?
    Jenn Rachelle U. Santos, Alessandra Brofferio, Bruna Viana, Karel Pacák · 2018 · Hormone and Metabolic Research
  9. New roles for dopamine D2 and D3 receptors in pancreatic beta cell insulin secretion
    Zachary J. Farino, Travis J. Morgenstern, Antonella Maffei, Matthias Quick, Alain J. De Solís, Pattama Wiriyasermkul, Robin J. Freyberg, Despoina Aslanoglou, Denise A. Sorisio, Benjamin Inbar et al. · 2019 · Molecular Psychiatry
  10. Bacterial Chat: Intestinal Metabolites and Signals in Host-Microbiota-Pathogen Interactions
    Bruna Cardinali Lustri, Vanessa Sperandio, Cristiano Gallina Moreira · 2017 · Infection and Immunity
  11. Validation of an ELISA for urinary dopamine: applications in monitoring treatment of dopamine‐related disorders
    Mikaela I. Nichkova, Paul M. Wynveen, David T. Marc, Han G. Huisman, Gottfried H. Kellermann · 2013 · Journal of Neurochemistry
  12. Sympathetic innervation, norepinephrine content, and norepinephrine turnover in orthotopic and spontaneous models of breast cancer
    Mercedes J. Szpunar, Elizabeth K. Belcher, Ryan P. Dawes, Kelley S. Madden · 2015 · Brain Behavior and Immunity
  13. Stress-Triggered Changes in Peripheral Catecholaminergic Systems
    Richard Květňanský, Xiaojiong Lu, Michael G. Ziegler · 2013 · Advances in pharmacology
  14. Distinct structure and activity of monoamine oxidase in the brain of zebrafish (Danio rerio)
    Oleg V. Anichtchik, Ville J. Sallinen, Nina Peitsaro, Pertti Panula · 2006 · The Journal of Comparative Neurology
  15. The skin function: a factor of anti-metabolic syndrome
    Shi‐Sheng Zhou, Da Li, Yiming Zhou, Ji-Min Cao · 2012 · Diabetology & Metabolic Syndrome
  16. Suppression of Heavy Drinking and Alcohol Seeking by a Selective ALDH‐2 Inhibitor
    María Pía Arolfo, David H. Overstreet, Lina Yao, Peidong Fan, Andrew John Lawrence, Guoxin Tao, Wing‐Ming Keung, Bert L. Vallée, Michael Foster Olive, Justin T. Gass et al. · 2009 · Alcoholism Clinical and Experimental Research
  17. The Presence of Caffeic Acid in Cerebrospinal Fluid: Evidence That Dietary Polyphenols Can Cross the Blood-Brain Barrier in Humans
    Izabela Grabska-Kobyłecka, Justyna Kaczmarek-Bąk, Małgorzata Figlus, Anna Prymont-Przymińska, Anna Zwolińska, Agata Sarniak, Anna Włodarczyk, Andrzej R Glabinski, Dariusz Nowak · 2020 · Nutrients
  18. Zinc in the Monoaminergic Theory of Depression: Its Relationship to Neural Plasticity
    Urszula Doboszewska, Piotr Właź, Gabriel Nowak, Maria Radziwoń-Zaleska, Ranji Cui, Katarzyna Młyniec · 2017 · Neural Plasticity
  19. Free radicals and sprint exercise in humans
    David Morales‐Álamo, José A. L. Calbet · 2013 · Free Radical Research
  20. Transcriptomic and Metabonomic Profiling of Obesity-Prone and Obesity-Resistant Rats under High Fat Diet
    Houkai Li, Zuoquan Xie, Jingchao Lin, Huaiguang Song, Qi Wang, Ke Wang, Mingming Su, Yunping Qiu, Tie Zhao, Kai Song et al. · 2008 · Journal of Proteome Research
  21. Physicochemical, Nutritional, and Medicinal Properties of Opuntia ficus-indica (L.) Mill. and Its Main Agro-Industrial Use: A Review
    Mariana Martins, Maria H.L. Ribeiro, Cristina M. M. Almeida · 2023 · Plants
  22. Tyrosine and tryptophan hydroxylases as therapeutic targets in human disease
    Kai Waløen, Rune Kleppe, Aurora Martı́nez, Jan Haavik · 2016 · Expert Opinion on Therapeutic Targets
  23. L-DOPA in Parkinson’s Disease: Looking at the “False” Neurotransmitters and Their Meaning
    Abdeslam Chagraoui, Marie Boulain, Laurent Juvin, Youssef Anouar, Grégory Barrière, Philippe De Deurwaerdère · 2019 · International Journal of Molecular Sciences
  24. Phaeochromocytoma and paraganglioma
    Vivian Andrew Fonseca, Pierre-Marc Gilles Bouloux · 1993 · Baillière s Clinical Endocrinology and Metabolism
  25. Manganese in human parenteral nutrition: Considerations for toxicity and biomonitoring
    Dinamene Marques dos Santos, M.C.C. Batoréu, M.L. Mateus, Ana Paula Marreilha dos Santos, Michael Aschner · 2013 · NeuroToxicology
  26. Metabologenomics of Phaeochromocytoma and Paraganglioma: An Integrated Approach for Personalised Biochemical and Genetic Testing.
    Graeme Eisenhofer, Barbara Klink, Susan Richter, Jacques W.M. Lenders, Mercedes Robledo · 2017 · Europe PMC (PubMed Central)
  27. Phenolic compounds that cross the blood–brain barrier exert positive health effects as central nervous system antioxidants
    Dafne Velásquez-Jiménez, Diana A. Corella‐Salazar, B. Shain Zuñiga-Martínez, Jesús Abraham Domínguez-Avila, Marcelino Montiel‐Herrera, Norma Julieta Salazar‐López, Joaquı́n Rodrigo-García, Mónica A. Villegas‐Ochoa, Gustavo Adolfo González-Aguilar · 2021 · Food & Function
  28. Pheochromocytoma as a catecholamine producing tumor: Implications for clinical practice
    Tomáš Zelinka, G. Eisenhofer, Karel Pacák · 2007 · Stress
  29. Lipid Peroxidation Products Inhibit Dopamine Catabolism Yielding Aberrant Levels of a Reactive Intermediate
    Jennifer Rees, Virginia R. Florang, David G. Anderson, Jonathan A. Doorn · 2007 · Chemical Research in Toxicology
  30. The pharmacological properties of antidepressants
    Giorgio Racagni, Maurizio Popoli · 2010 · International Clinical Psychopharmacology
  31. Hypertension: The role of biochemistry in the diagnosis and management
    Paula Mary O’Shea, Tomás Patrick Griffin, Maria C. Fitzgibbon · 2016 · Clinica Chimica Acta
  32. Beta blockers in critically ill patients with traumatic brain injury: Results from a multicenter, prospective, observational American Association for the Surgery of Trauma study
    Eric Jude Ley, Samuel D. Leonard, Galinos Barmparas, Navpreet K. Dhillon, Kenji Inaba, Alí Salim, Karen R. O’Bosky, Danielle M. Tatum, Hooman Azmi, Chad G. Ball et al. · 2017 · The Journal of Trauma: Injury, Infection, and Critical Care
  33. Influence of Stroke Localization on Autonomic Activation, Immunodepression, and Post-Stroke Infection
    Hendrik Harms, Peter Reimnitz, Georg Böhner, Tabea Werich, Randolf Klingebiel, Christian Meisel, Andreas Meisel · 2011 · Cerebrovascular Diseases
  34. Metabolic differences underlying two distinct rat urinary phenotypes, a suggested role for gut microbial metabolism of phenylalanine and a possible connection to autism
    T. Andrew Clayton · 2012 · FEBS Letters
  35. Are dopamine derivatives implicated in the pathogenesis of Parkinson's disease?
    Marco Bisaglia, Roberta Filograna, Mariano Beltramini, Luigi Bubacco · 2014 · Ageing Research Reviews
  36. FV 12 The integrity of dopaminergic and noradrenergic brain regions is associated with different aspects of late-life memory performance
    M. Dahl, S. Bachman, S. Dutt, Sandra Düzel, Nils Bodammer, Ulman Lindenberger, Simone Kühn, Markus Werkle‐Bergner, Mara Mather · 2023 · Clinical Neurophysiology
  37. Modulation of Adrenal Catecholamine Secretion by In Vivo Gene Transfer and Manipulation of G Protein–coupled Receptor Kinase-2 Activity
    Anastasios Lymperopoulos, Giuseppe Rengo, Carmela Zincarelli, Stephen Soltys, Walter J. Koch · 2008 · Molecular Therapy
  38. Vesicular uptake blockade generates the toxic dopamine metabolite 3,4‐dihydroxyphenylacetaldehyde in PC 12 cells: relevance to the pathogenesis of Parkinson's disease
    David S. Goldstein, Patti Sullivan, Adele M. Cooney, Yunden Jinsmaa, Rachel Sullivan, Daniel Gross, Courtney S. Holmes, Irwin J. Kopin, Yehonatan Sharabi · 2012 · Journal of Neurochemistry
  39. Determination of catecholamines in plasma and urine
    Eric Grouzmann, Faïza Lamine · 2013 · Best Practice & Research Clinical Endocrinology & Metabolism
  40. Silent pheochromocytoma and paraganglioma: Systematic review and proposed definitions for standardized terminology
    Georgiana Andreea Constantinescu, Cristina Preda, Victor Constantinescu, Timo Siepmann, Stefan Richard Bornstein, Jacques W.M. Lenders, Graeme Eisenhofer, Christina Pamporaki · 2022 · Frontiers in Endocrinology
  41. Identification of catecholamine neurotransmitters using fluorescence sensor array
    Forough Ghasemi, Mohammad Reza Hormozi-Nezhad, Morteza Mahmoudi · 2016 · Analytica Chimica Acta
  42. Atomoxetine in patients with ADHD: A clinical and pharmacological review of the onset, trajectory, duration of response and implications for patients
    David B. Clemow, Chris Bushe · 2015 · Journal of Psychopharmacology
  43. Pheochromocytomas and paragangliomas in humans and dogs
    Sara Galac, Esther Korpershoek · 2017 · Veterinary and Comparative Oncology
  44. Catecholamine physiology and its implications in patients with COVID-19
    Sriram Gubbi, Matthew A. Nazari, David Taïeb, Joanna Kłubo-Gwieździńska, Karel Pacák · 2020 · The Lancet Diabetes & Endocrinology
  45. Monoaminergic and Histaminergic Strategies and Treatments in Brain Diseases
    Giuseppe Di Giovanni, Dubravka Švob Štrac, Montse Solé, Mercedes Unzeta, Keith Francis Tipton, Dorotea Mück‐Šeler, Irene Bolea, Laura Corte, Matea Nikolac Perković, Nela Pivac et al. · 2016 · Frontiers in Neuroscience
  46. Pheochromocytoma and Paraganglioma
    Karel Pacák, Sunil J. Wimalawansa · 2015 · Endocrine Practice
  47. Bornyl acetate: A promising agent in phytomedicine for inflammation and immune modulation
    Zhejun Zhao, Yuanlong Sun, Xiaofen Ruan · 2023 · Phytomedicine
  48. Mutations in PRKN and SNCA Genes Important for the Progress of Parkinson’s Disease
    Anna Oczkowska, Wojciech P. Kozubski, Margarita Lianeri, Jolanta Dorszewska · 2014 · Current Genomics
  49. Adrenaline but not noradrenaline is a determinant of exercise‐induced lipid mobilization in human subcutaneous adipose tissue
    Isabelle de Glisezinski, Dominique Larrouy, Magda Bajzová, Katrien Koppo, Jan Polak, M Berlan, Jens Bülow, Dominique Langin, M Marques, F. Crampes et al. · 2009 · The Journal of Physiology
  50. Interest of systematic screening of pheochromocytoma in patients with neurofibromatosis type 1
    Lori Képénékian, Thomas Mognetti, Jean‐Christophe Lifante, Anne‐Laure Giraudet, C. Houzard, S. Pinson, Françoise Borson‐Chazot, P. Combemale · 2016 · European Journal of Endocrinology
  51. Antipsychotic Drug Responsiveness and Dopamine Receptor Signaling; Old Players and New Prospects
    Antonio Rampino, Aleksandra Marakhovskaia, Tiago Soares-Silva, Silvia Torretta, Federica Veneziani, Jean‐Martin Beaulieu · 2019 · Frontiers in Psychiatry
  52. Chromogranin A Deficiency in Transgenic Mice Leads to Aberrant Chromaffin Granule Biogenesis
    Taeyoon Kim, Chun-fa Zhang, Ziqing Sun, Heling Wu, Y. Peng Loh · 2005 · Journal of Neuroscience
  53. Multiple tyrosine metabolites are GPR35 agonists
    Huayun Deng, Haibei Hu, Fang Ye · 2012 · Scientific Reports
  54. The Chromaffin Vesicle: Advances in Understanding the Composition of a Versatile, Multifunctional Secretory Organelle
    Enrico Crivellato B, Beatrice Nico, Doménico Ribatti · 2008 · The Anatomical Record
  55. Toxoplasma gondii Infection in Mice Impairs Long-Term Fear Memory Consolidation through Dysfunction of the Cortex and Amygdala
    Fumiaki Ihara, Maki Nishimura, Yoshikage Muroi, Motamed Elsayed Mahmoud, Naoaki Yokoyama, Kisaburo Nagamune, Yoshifumi Nishikawa · 2016 · Infection and Immunity
  56. Revisiting the Role of Astrocytic MAOB in Parkinson’s Disease
    Min‐Ho Nam, Moonsun Sa, Yeon Ha Ju, Mingu Gordon Park, Changjoon Justin Lee · 2022 · International Journal of Molecular Sciences
  57. Catechol-O-Methyltransferase and Pain
    Oleg Kambur, Pekka T. Männistö · 2010 · International review of neurobiology
  58. Pattern of anxiety, insecurity, fear, panic and/or phobia observed by quantitative electroencephalography (QEEG)
    Valdenilson Ribeiro Ribas, Renata de Melo Guerra Ribas, Jean de Almeida Nóbrega, Marcília Vieira da Nóbrega, Juliana Azevedo de Andrade Espécie, Murilo Tolêdo Calafange, Clenes de Oliveira Mendes Calafange, Hugo André de Lima Martins · 2018 · Dementia & Neuropsychologia
  59. Are genetic variants of COMT associated with addiction?
    Anne Tammimäki, Pekka T. Männistö · 2010 · Pharmacogenetics and Genomics
  60. Increased Vesicular Monoamine Transporter 2 (VMAT2;Slc18a2) Protects against Methamphetamine Toxicity
    Kelly M. Lohr, Kristen A. Stout, Amy R. Dunn, Minzheng Wang, Ali Salahpour, Thomas S. Guillot, Gary Wright Miller · 2015 · ACS Chemical Neuroscience
  61. First Experimental Evidence of Dopamine Interactions with Negatively Charged Model Biomembranes
    Katarzyna Jodko-Piórecka, Grzegorz Litwinienko · 2013 · ACS Chemical Neuroscience
  62. Effects of an Environmentally Relevant PFAS Mixture on Dopamine and Steroid Hormone Levels in Exposed Mice
    Grønnestad, Randi, Johanson, Silje Modahl, Müller, Mette H.B., Schlenk, Daniel, Tanabe, Philip, Krøkje, Åse, Jaspers, Veerle L.B., Jenssen, Bjørn Munro, Ræder, Erik M., Lyche, Jan L. et al. · 2021 · Toxicology and Applied Pharmacology
  63. Dopamine, Erectile Function and Male Sexual Behavior from the Past to the Present: A Review
    Maria Rosaria Melis, Fabrizio Sanna, Antonio Argiolas · 2022 · Brain Sciences
  64. Chemotaxis of Escherichia coli to Norepinephrine (NE) Requires Conversion of NE to 3,4-Dihydroxymandelic Acid
    Sasikiran Pasupuleti, Nitesh Sule, William B. Cohn, Duncan S. MacKenzie, Arul Jayaraman, Michael D. Manson · 2014 · Journal of Bacteriology
  65. Salsolinol: an Unintelligible and Double-Faced Molecule—Lessons Learned from In Vivo and In Vitro Experiments
    Magdalena Kurnik‐Łucka, Pertti Panula, Andrzej J. Bugajski, Krzysztof Gil · 2017 · Neurotoxicity Research
  66. Common Drugs Inhibit Human Organic Cation Transporter 1 (OCT1)-Mediated Neurotransmitter Uptake
    Kelli H. Boxberger, Bruno Hagenbuch, Jed Noah Lampe · 2014 · Drug Metabolism and Disposition
  67. Recent Advances in Characterization of Melanin Pigments in Biological Samples
    Kazumasa Wakamatsu, Shosuke Ito · 2023 · International Journal of Molecular Sciences
  68. Brain white matter structure and COMT gene are linked to second-language learning in adults
    Ping Chao Mamiya, Todd L. Richards, Bradley P. Coe, Evan E. Eichler, Patricia K. Kuhl · 2016 · Proceedings of the National Academy of Sciences
  69. Phaeochromocytoma and Paraganglioma
    P. T. Kavinga Gunawardane, Ashley Barry Grossman · 2016 · Advances in experimental medicine and biology
  70. Genomics and biochemistry investigation on the metabolic pathway of milled wood and alkali lignin-derived aromatic metabolites of Comamonas serinivorans SP-35
    Daochen Zhu, Haibing Si, Peipei Zhang, Alei Geng, Weimin Zhang, Bin Yang, Weijun Qian, Gabriel Murillo, Jianzhong Sun · 2018 · Biotechnology for Biofuels
  71. Dopamine, endocannabinoids and their interaction in fear extinction and negative affect in PTSD
    Luke John Ney, Jane Akhurst, Raimondo Bruno, Patrick A.F. Laing, Allison Jane Matthews, Kim Louise Felmingham · 2020 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  72. GPCR-Based Dopamine Sensors—A Detailed Guide to Inform Sensor Choice for In Vivo Imaging
    Marie A. Labouesse, Reto B. Cola, Tommaso Patriarchi · 2020 · International Journal of Molecular Sciences
  73. Opportunistic use of catecholamine neurotransmitters as siderophores to access iron by Pseudomonas aeruginosa
    Quentin Perraud, Lauriane Kühn, Sarah Fritsch, Gwenaëlle Graulier, Véronique Gasser, Vincent Normant, Philippe Hammann, Isabelle J. Schalk · 2020 · Environmental Microbiology
  74. Application of a mercapto-terminated binuclear Cu(II) complex modified Au electrode to improve the sensitivity and selectivity for dopamine detection
    Guomin Jiang, Xuefang Gu, Guoqing Jiang, Tingting Chen, Wenyi Zhan, Shu Tian · 2014 · Sensors and Actuators B Chemical
  75. Exercise–Cognition Interaction
    Terry McMorris · 2015 · Elsevier eBooks
  76. Dopamine-derived biological reactive intermediates and protein modifications: Implications for Parkinson's disease
    Yunden Jinsmaa, Virginia R. Florang, Jennifer Rees, Lydia M.M. Vermeer, Laurie L. Eckert, Erin M. G. Allen, David G. Anderson, Jonathan A. Doorn · 2011 · Chemico-Biological Interactions
  77. Differential neurochemical consequences of an escalating dose‐binge regimen followed by single‐day multiple‐dose methamphetamine challenges
    Devon L. Graham, Pierre-A.H. Noailles, Jean Lud Cadet · 2008 · Journal of Neurochemistry
  78. Influence of exposure to coarse, fine and ultrafine urban particulate matter and their biological constituents on neural biomarkers in a randomized controlled crossover study
    Ling Liu, Bruce Urch, Mieczysław Szyszkowicz, Mary Speck, Karen Leingartner, Robin Shutt, Guillaume Pelletier, Diane R. Gold, James A. Scott, Jeffrey Robert Brook et al. · 2017 · Environment International
  79. Postoperative Management in Patients with Pheochromocytoma and Paraganglioma
    Divya Mamilla, Katherine Araque, Alessandra Brofferio, Melissa Gonzales, James Sullivan, Naris Nilubol, Karel Pacák · 2019 · Cancers
  80. Plasma-Free Metanephrine and Free Normetanephrine Measurement for the Diagnosis of Pheochromocytoma in Dogs
    Ruth Gostelow, N. Bridger, Harriet M. Syme · 2013 · Journal of Veterinary Internal Medicine
  81. Performance characteristics of an LC–MS/MS method for the determination of plasma metanephrines
    Brian J. Petteys, Kendon S. Graham, M. Laura Parnas, Crystal Holt, Elizabeth L. Frank · 2012 · Clinica Chimica Acta
  82. The role of tyrosine hydroxylase as a key player in neuromelanin synthesis and the association of neuromelanin with Parkinson’s disease
    Toshiharu Nagatsu, Akira Nakashima, Hirohisa Watanabe, Shosuke Ito, Kazumasa Wakamatsu, Fabio Andrea Zucca, Luigi Zecca, Moussa B. H. Youdim, Maximilian Wulf, Peter Franz Riederer et al. · 2023 · Journal of Neural Transmission
  83. Sympathetic dysfunction in vasovagal syncope and the postural orthostatic tachycardia syndrome
    Élisabeth Lambert, Gavin William Lambert · 2014 · Frontiers in Physiology
  84. Urinary Neurotransmitters Are Selectively Altered in Children With Obstructive Sleep Apnea and Predict Cognitive Morbidity
    David Gozal, Corena J.T. McManus, Gottfried H. Kellermann, Arash Samiei, David Gozal · 2013 · CHEST Journal
  85. Progress in Target Drug Molecules for Alzheimer's Disease
    Jiayang Xie, Ruirui Liang, Yan‐Jiang Wang, Junyi Huang, Xin Cao, Bing Niu · 2019 · Current Topics in Medicinal Chemistry
  86. Tau modification by the norepinephrine metabolite DOPEGAL stimulates its pathology and propagation
    Seong Su Kang, Lanxia Meng, Xingyu Zhang, Zhiping Wu, Ariana Mancieri, Boer Xie, Xia Liu, David Weinshenker, Junmin Peng, Zhentao Zhang et al. · 2022 · Nature Structural & Molecular Biology
  87. Pheochromocytoma/paraganglioma-associated cardiomyopathy
    Alicja Szatko, Piotr Glinicki, Małgorzata Gietka‐Czernel · 2023 · Frontiers in Endocrinology
  88. Polymorphism of the COMT, MAO, DAT, NET and 5-HTT Genes, and Biogenic Amines in Parkinson’s Disease
    Jolanta Dorszewska, Michał Prendecki, Anna Oczkowska, Agata Różycka, Margarita Lianeri, Wojciech P. Kozubski · 2014 · Current Genomics
  89. Isopropanol Protein Precipitation for the Analysis of Plasma Free Metanephrines by Liquid Chromatography–Tandem Mass Spectrometry
    Luke C. Marney, Thomas J. Laha, Geoffrey Stuart Baird, Petrie M. Rainey, Andrew N. Hoofnagle · 2008 · Clinical Chemistry
  90. Vanillylmandelic and Homovanillic acid: Electroanalysis at non-modified and polymer-modified carbon-based electrodes
    Simona Baluchová, Jiřı́ Barek, Luciana I. N. Tomé, Christopher M. A. Brett, Karolina Schwarzová‐Pecková · 2018 · Journal of Electroanalytical Chemistry
  91. Study of BDE-47 induced Parkinson’s disease-like metabolic changes in C57BL/6 mice by integrated metabolomic, lipidomic and proteomic analysis
    Fenfen Ji, Sravan Gopalkrishnashetty Sreenivasmurthy, Juntong Wei, Xiaojian Shao, Hemi Luan, Lin Zhu, Ju‐Xian Song, Liangfeng Liu, Min Li, Zongwei Cai · 2019 · Journal of Hazardous Materials
  92. Dopamine Is a Low-Affinity and High-Specificity Substrate for the Human UDP-Glucuronosyltransferase 1A10
    Katriina Itäaho, Michael H. Court, Päivi Uutela, Risto K. Kostiainen, Anna Radominska-p, Moshe Finel · 2008 · Drug Metabolism and Disposition
  93. Sympathoadrenal function in patients with paroxysmal hypertension: pseudopheochromocytoma
    Yehonatan Sharabi, David S. Goldstein, Oladi Bentho, Ahmed Saleem, Sandra Pechnik, Marilla F. Geraci, Courtney S. Holmes, Karel Pacák, Graeme Eisenhofer · 2007 · Journal of Hypertension
  94. Urinary sampling for 5HIAA and metanephrines determination: revisiting the recommendations
    Jean‐Benoît Corcuff, Laurence Chardon, Ines El Hajji-Ridah, Julie Brossaud · 2017 · Endocrine Connections
  95. Probiotics Affect One‐Carbon Metabolites and Catecholamines in a Genetic Rat Model of Depression
    Sandra Tillmann, Hussain Mohamad Awwad, Amanda Eskelund, Giulia Treccani, Jürgen Geisel, Gregers Wegener, Rima Obeid · 2018 · Molecular Nutrition & Food Research
  96. Plasma catecholamine and nephrine responses to brief intermittent maximal intensity exercise
    Richard M. Bracken, Denise M. Linnane, Stephen Brooks · 2008 · Amino Acids
  97. The Implications of Relationships between Human Diseases and Metabolic Subpathways
    Xia Li, Chunquan Li, Desi Shang, Jing Li, Junwei Han, Yingbo Miao, Yan Wang, Qianghu Wang, Wei Li, Chao Wu et al. · 2011 · PLoS ONE
  98. A study on the stability of urinary free catecholamines and free methyl-derivatives at different pH, temperature and time of storage
    Norman B. Roberts, Gerald Higgins, Mansour Sargazi · 2009 · Clinical Chemistry and Laboratory Medicine (CCLM)
  99. Lactic-Acid Bacteria Supplement Fermented Dairy Products with Human Behavior-Modifying Neuroactive Compounds
    Alexander V. Oleskin, O. G. Zhilenkova, Shenderov Ba, Adelaide M. Amerhanova, В. С. Кудрин, Клодт Петр Михайлович · 2014 · Journal of Pharmacy and Nutrition Sciences
  100. Alcohol consumption is associated with high concentrations of urinary hydroxytyrosol
    Helmut Schröder, Rafael de la Torre, Ramón Estruch, Dolores Corella, Miguel Ángel Martínez‐González, Jordi Salas‐Salvadó, Emilio Ros, Fernando Arós, Gemma Flores, Ester Civit et al. · 2009 · American Journal of Clinical Nutrition